These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 38559562)

  • 1. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
    William JNG; Dhar R; Gundamaraju R; Sahoo OS; Pethusamy K; Raj AFPAM; Ramasamy S; Alqahtani MS; Abbas M; Karmakar S
    Front Oncol; 2024; 14():1288501. PubMed ID: 38559562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated expression of SKP2 and its role in hematological malignancies.
    Kulinski M; Achkar IW; Haris M; Dermime S; Mohammad RM; Uddin S
    Leuk Lymphoma; 2018 May; 59(5):1051-1063. PubMed ID: 28797197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E3 ubiquitin ligase Skp2 as an attractive target in cancer therapy.
    Hao Z; Huang S
    Front Biosci (Landmark Ed); 2015 Jan; 20(3):474-90. PubMed ID: 25553462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization.
    Bashir T; Pagan JK; Busino L; Pagano M
    Cell Cycle; 2010 Mar; 9(5):971-4. PubMed ID: 20160477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
    Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
    Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
    Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
    EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
    Chen Q; Xie W; Kuhn DJ; Voorhees PM; Lopez-Girona A; Mendy D; Corral LG; Krenitsky VP; Xu W; Moutouh-de Parseval L; Webb DR; Mercurio F; Nakayama KI; Nakayama K; Orlowski RZ
    Blood; 2008 May; 111(9):4690-9. PubMed ID: 18305219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human papillomavirus type 18 E2 protein is a cell cycle-dependent target of the SCFSkp2 ubiquitin ligase.
    Bellanger S; Tan CL; Nei W; He PP; Thierry F
    J Virol; 2010 Jan; 84(1):437-44. PubMed ID: 19828607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.
    Chan CH; Morrow JK; Li CF; Gao Y; Jin G; Moten A; Stagg LJ; Ladbury JE; Cai Z; Xu D; Logothetis CJ; Hung MC; Zhang S; Lin HK
    Cell; 2013 Aug; 154(3):556-68. PubMed ID: 23911321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells.
    Harada K; Supriatno ; Kawashima Y; Itashiki Y; Yoshida H; Sato M
    Oral Oncol; 2005 Jul; 41(6):623-30. PubMed ID: 16050017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation.
    Penin RM; Fernandez-Figueras MT; Puig L; Rex J; Ferrandiz C; Ariza A
    Mod Pathol; 2002 Nov; 15(11):1227-35. PubMed ID: 12429803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells.
    Bretones G; Acosta JC; Caraballo JM; Ferrándiz N; Gómez-Casares MT; Albajar M; Blanco R; Ruiz P; Hung WC; Albero MP; Perez-Roger I; León J
    J Biol Chem; 2011 Mar; 286(11):9815-25. PubMed ID: 21245140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
    Gupta P; Zhao H; Hoang B; Schwartz EL
    Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.